More Articles
Approval of generic glucagon for management of hypoglycemia Prepared by: Kristal Matlock, Preneet Cheema Brar, Molly Regelmann UpToDate as of: 1/20/2021 On December 28, 2020, the U.S. Food and Drug…
Read MoreSetmelanotide Prepared by: Anshu Gupta, MD, MS and Brenda Kohn, MD Up-to-date as of December 14, 2020 On November 27, 2020, setmelanotide (IMCIVREE™; Rhythm Pharmaceuticals, Inc.), a melanocortin-4 (MC4) receptor…
Read MoreMcCune-Albright syndrome (D.J. McCune, MD (1902-1976), Fuller Albright MD (1900-1969) Submitted by: Alan D. Rogol, MD, Ph.D In 1936 McCune described a patient with disseminated osteitis fibrosa, skin pigmentation, precocious…
Read MoreI am currently a 2nd year fellow in the UCSF pediatric endocrinology program. Most of my time currently is spent doing research, clinical work, and taking classes in the Advanced Training…
Read MoreSaxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page, MD and Shilpa Mehta, MD Up to date as of December 10, 2020 On December 4, 2020, the FDA approved…
Read MoreJean H. Dussault, MD Working with our 10th president, Del Fisher, JH Dussault adapted a method for the determination of thyroxine by RIA to blood spots used for newborn PKU…
Read MoreHydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks and Kyriakie Sarafoglou Up to date as of: November 4, 2020 On September 29, 2020, the United States Food and…
Read MoreFuller Albright, MD (1900-1969), Albright’s hereditary osteodystrophy Albright described a syndrome in children characterized by short stature, short neck, obesity, subcutaneous calcifications, shortened metacarpals with hypocalcemia and hyperphosphatemia (Endocrinology 1942;…
Read More